![Michal Korostynski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Michal Korostynski is the founder and Chief Scientific Officer of Intelliseq SA, which is founded in 2014.
Aktive Positionen von Michal Korostynski
Unternehmen | Position | Beginn |
---|---|---|
Intelliseq SA
![]() Intelliseq SA Internet Software/ServicesTechnology Services Intelliseq SA is a Polish genome informatics company that specializes in creating algorithms and bioinformatic tools to interpret the human DNA sequence. The company was founded in 2014 by Marcin Piechota, Michal Korostynski, Slawomir Golda, and is currently based in Kraków, Poland. Intelliseq's interdisciplinary team of experts in genomics, molecular biology, bioinformatics, and software development aims to support whole-genome scientific research and the genetic diagnosis process. The company delivers an automatic and scalable SaaS platform for genome data analysis with no upfront cost. The company's goal is to fill a void in translating genetics knowledge into products and make DNA analysis simple. | Gründer | 01.01.2014 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Intelliseq SA
![]() Intelliseq SA Internet Software/ServicesTechnology Services Intelliseq SA is a Polish genome informatics company that specializes in creating algorithms and bioinformatic tools to interpret the human DNA sequence. The company was founded in 2014 by Marcin Piechota, Michal Korostynski, Slawomir Golda, and is currently based in Kraków, Poland. Intelliseq's interdisciplinary team of experts in genomics, molecular biology, bioinformatics, and software development aims to support whole-genome scientific research and the genetic diagnosis process. The company delivers an automatic and scalable SaaS platform for genome data analysis with no upfront cost. The company's goal is to fill a void in translating genetics knowledge into products and make DNA analysis simple. | Technology Services |